These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 32792018)

  • 1. High-dose intravenous vitamin C may help in cytokine storm in severe SARS-CoV-2 infection.
    de Melo AF; Homem-de-Mello M
    Crit Care; 2020 Aug; 24(1):500. PubMed ID: 32792018
    [No Abstract]   [Full Text] [Related]  

  • 2. Cytokines and COVID-19: friends or foes?
    Rokni M; Hamblin MR; Rezaei N
    Hum Vaccin Immunother; 2020 Oct; 16(10):2363-2365. PubMed ID: 32841579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 infection complicated by inflammatory syndrome. Could high-dose human immunoglobulin for intravenous use (IVIG) be beneficial?
    Prete M; Favoino E; Catacchio G; Racanelli V; Perosa F
    Autoimmun Rev; 2020 Jul; 19(7):102559. PubMed ID: 32361195
    [No Abstract]   [Full Text] [Related]  

  • 4. Contribution of monocytes and macrophages to the local tissue inflammation and cytokine storm in COVID-19: Lessons from SARS and MERS, and potential therapeutic interventions.
    Jafarzadeh A; Chauhan P; Saha B; Jafarzadeh S; Nemati M
    Life Sci; 2020 Sep; 257():118102. PubMed ID: 32687918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune environment modulation in pneumonia patients caused by coronavirus: SARS-CoV, MERS-CoV and SARS-CoV-2.
    Yao Z; Zheng Z; Wu K; Junhua Z
    Aging (Albany NY); 2020 May; 12(9):7639-7651. PubMed ID: 32364527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative overview of COVID-19, MERS and SARS: Review article.
    Liu J; Xie W; Wang Y; Xiong Y; Chen S; Han J; Wu Q
    Int J Surg; 2020 Sep; 81():1-8. PubMed ID: 32730205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Commentary on "A comparative overview of COVID-19, MERS and SARS: Review article" (International Journal of Surgery 2020; 81:1-8).
    Awais S; Shah SFH; Shah SGS
    Int J Surg; 2020 Nov; 83():28-29. PubMed ID: 32927142
    [No Abstract]   [Full Text] [Related]  

  • 8. Hazards of the Cytokine Storm and Cytokine-Targeted Therapy in Patients With COVID-19: Review.
    Quirch M; Lee J; Rehman S
    J Med Internet Res; 2020 Aug; 22(8):e20193. PubMed ID: 32707537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baricitinib, a drug with potential effect to prevent SARS-COV-2 from entering target cells and control cytokine storm induced by COVID-19.
    Zhang X; Zhang Y; Qiao W; Zhang J; Qi Z
    Int Immunopharmacol; 2020 Sep; 86():106749. PubMed ID: 32645632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex-biased Immune Responses Following SARS-CoV-2 Infection.
    Ursin RL; Shapiro JR; Klein SL
    Trends Microbiol; 2020 Dec; 28(12):952-954. PubMed ID: 33077340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine storm induced by SARS-CoV-2.
    Song P; Li W; Xie J; Hou Y; You C
    Clin Chim Acta; 2020 Oct; 509():280-287. PubMed ID: 32531256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of coronavirus disease-19 (COVID-19) based on SARS autopsy].
    Ding YQ; Bian XW
    Zhonghua Bing Li Xue Za Zhi; 2020 Apr; 49(4):291-293. PubMed ID: 32268662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [SARS-CoV-2 (COVID-19) as a predictor of neuroinflammation and neurodegeneration: potential therapy strategies].
    Putilina MV; Grishin DV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(8. Vyp. 2):58-64. PubMed ID: 33016678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Low-Pathogenic Human Coronavirus-Specific Antibodies on SARS-CoV-2.
    Jiang S; Du L
    Trends Immunol; 2020 Oct; 41(10):853-854. PubMed ID: 32863133
    [No Abstract]   [Full Text] [Related]  

  • 15. A glimpse into the eye of the COVID-19 cytokine storm.
    Kuppalli K; Rasmussen AL
    EBioMedicine; 2020 May; 55():102789. PubMed ID: 32388462
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of clinical characteristics of coronavirus disease (COVID-19) and severe acute respiratory syndrome (SARS) as experienced in Taiwan.
    Su YJ; Lai YC
    Travel Med Infect Dis; 2020; 36():101625. PubMed ID: 32184131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coagulopathy and mesenteric ischaemia in severe SARS-CoV-2 infection.
    English W; Banerjee S
    ANZ J Surg; 2020 Sep; 90(9):1826. PubMed ID: 32621375
    [No Abstract]   [Full Text] [Related]  

  • 18. Origin of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and COVID-19.
    Byard RW; Hunsaker J; Tsokos M
    Forensic Sci Med Pathol; 2020 Dec; 16(4):745. PubMed ID: 33104977
    [No Abstract]   [Full Text] [Related]  

  • 19. Mortality from COVID-19: are we getting closer to the true value?
    Fonzo M; Bertoncello C; Baldo V
    Pathog Glob Health; 2020 Oct; 114(7):347-348. PubMed ID: 33012277
    [No Abstract]   [Full Text] [Related]  

  • 20. Good IgA Bad IgG in SARS-CoV-2 Infection?
    Béné MC; de Carvalho Bittencourt M; Eveillard M; Le Bris Y
    Clin Infect Dis; 2020 Jul; 71(15):897-898. PubMed ID: 32280952
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.